Additionally, overexpression of C1q/tumor necrosis factor-related protein 5 (CTRP5) activates the AMPKα2 signaling pathway, leading to increased PGC-1α expression, reduced ischemia-reperfusion injury, and improved infarct-induced HF outcomes (135). This evidence concerns the gene PPARGC1A and hydrops fetalis.